Virios therapeutics to report first quarter 2023 financial results on thursday, may 11, 2023

Atlanta, ga., may 04, 2023 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri) (the “company”), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“fm”), today announced that it will report first quarter 2023 financial results on thursday, may 11, 2023 before the open of the financial markets.
VIRI Ratings Summary
VIRI Quant Ranking